Greater than 97.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Interleukin-7 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 152 amino acids and having a molecular mass of 17.4 kDa.
The IL-7 is purified by proprietary chromatographic techniques.
DCDIEGKDG KQYESVLMVS IDQLLDSMKE IGSNCLNNEF NFFKRHICDA NKEGMFLFRA ARKLRQFLKM NSTGDFDLHL LKVSEGTTIL LNCTGQVKGR KPAALGEAQP TKSLEENKSL KEQKKLNDLC FLKRLLQEIK TCWNKILMGT KEH.
IL-7 is a 25-kDa soluble globular protein. The recombinant form of IL-7, known as Human Recombinant IL-7, is produced using recombinant DNA technology, typically in E. coli . This recombinant form is used extensively in research and clinical settings due to its ability to stimulate the proliferation and differentiation of lymphoid progenitors .
IL-7 plays a vital role in the immune system by:
IL-7 exerts its effects through a heterodimeric receptor composed of the IL-7 receptor α-chain (CD127) and the common cytokine receptor γ-chain . This receptor is expressed on various immune cells, including early thymocytes, T cells, pre-B cells, and bone marrow macrophages . Binding of IL-7 to its receptor activates several signaling pathways that promote cell survival, proliferation, and differentiation .
Recombinant IL-7 has shown promise in clinical trials for its ability to restore and maintain lymphocyte counts, particularly CD4+ and CD8+ T cells . This makes it a potential therapeutic agent for conditions involving immune deficiency or depletion, such as HIV infection, cancer, and after bone marrow transplantation .